Dengue Hemorragic Fever

  • Upload
    atiafr

  • View
    219

  • Download
    0

Embed Size (px)

Citation preview

  • 8/11/2019 Dengue Hemorragic Fever

    1/93

    Update on

    Management of

    PediatricDengue

    YuliaIriani

  • 8/11/2019 Dengue Hemorragic Fever

    2/93

  • 8/11/2019 Dengue Hemorragic Fever

    3/93

    Disease burden

    Indonesia:

    - Maor public healthproblem.

    - eading cause ofhospitali&a! on and

    death amongchildren.

    - 0$perendemicit$ with all1 serot$pes circula!ng in

    urban areas.

    - preading to rural areas.

    mailto:hospitaliza@onmailto:hospitaliza@onmailto:hospitaliza@onmailto:hospitaliza@onmailto:hospitaliza@onmailto:circula@ngmailto:circula@ngmailto:circula@ngmailto:circula@ngmailto:hospitaliza@onmailto:circula@ng
  • 8/11/2019 Dengue Hemorragic Fever

    4/93

    3auses of D04 Death

    Dela$ed diagnosis

    6PD prolonged shoc"

    7PD 8uid o9erload b$ h$potonic

    solu!ons :5( D/ ;/2 at M rate

  • 8/11/2019 Dengue Hemorragic Fever

    5/93

    Prolonged shoc" grade

    7=

    >ithout proper treatment

    + 1

    hours

    o 0epa!c failure prognosis 5#(

    sur9i9al o ? @enal failure

    prognosis ,#( sur9i9al o ? A

    organ

    failure

    prognosis

    Miracle

    + ,#

    hours

    Death

    mailto:Hepa@cmailto:Hepa@c
  • 8/11/2019 Dengue Hemorragic Fever

    6/93

    Coals of dengue

    management

    @ecogni&e dengue

    infec!on at an

    earl$

    stage

    Detect the earl$ onset of plasmalea"age

    in

    these pa!ents

    and

    Eppropriatel$ manage

    deh$dra!on

    and

    h$po9olemia.

    @educe

    mortalit$

    and

    morbidit$

    mailto:infec@onmailto:infec@onmailto:infec@onmailto:infec@onmailto:infec@onmailto:pa@entsmailto:pa@entsmailto:pa@entsmailto:pa@entsmailto:dehydra@onmailto:dehydra@onmailto:dehydra@onmailto:dehydra@onmailto:dehydra@onmailto:infec@onmailto:pa@entsmailto:dehydra@on
  • 8/11/2019 Dengue Hemorragic Fever

    7/93

    =irusF =ector and

    Gransmission

  • 8/11/2019 Dengue Hemorragic Fever

    8/93

    *thiological agent

  • 8/11/2019 Dengue Hemorragic Fever

    9/93

    Aedes aegyp*

  • 8/11/2019 Dengue Hemorragic Fever

    10/93

    Dengue transmission

  • 8/11/2019 Dengue Hemorragic Fever

    11/93

    Disease

    Pathogenesis

  • 8/11/2019 Dengue Hemorragic Fever

    12/93

    3urrent 0$pothesis

    D*;= tropism 3ells of the immune s$stem 6rgan patholog$ *ndothelial cells

    =irus 9irulence

    En!bod$HIDependent *nhancement

    3omplement s$stem ac!9a!on Eutoimmunit$ 0ost gene!c factors 3rossHI@eac!9eGHI3ell response

    mailto:An@body-mailto:An@body-mailto:An@body-mailto:An@body-mailto:ac@vamailto:ac@vamailto:ac@vamailto:ac@vamailto:ac@vamailto:ac@vamailto:ac@vamailto:gene@cmailto:gene@cmailto:gene@cmailto:gene@cmailto:Reac@vemailto:Reac@vemailto:Reac@vemailto:Reac@vemailto:An@body-mailto:ac@vamailto:gene@cmailto:Reac@ve
  • 8/11/2019 Dengue Hemorragic Fever

    13/93

  • 8/11/2019 Dengue Hemorragic Fever

    14/93

    Proposed model of heterologous immunit$ in secondar$ dengue 9irus infec!ons and its implica!ons for the

    pathogenesis of dengue hemorrhagic fe9er. Primar$ D*;=HI2 infec!on and se%uen!al D*;=HI, and D*;=HI2 infec!onsare

    compared

    for

    illustra!on

    purposes.

    Ghe

    nai9e

    G

    cell

    repertoire

    :pale

    colors06/GD@

    2##'

    SDengue is

    one

    disease

    en!t$

    with

    diJerent clinical

    presenta! ons and

    osen with unpredictable clinical

    e9olu!on

    and

    outcomeT

    mailto:en@tymailto:en@tymailto:en@tymailto:en@tymailto:en@tymailto:presenta@onsmailto:presenta@onsmailto:presenta@onsmailto:presenta@onsmailto:presenta@onsmailto:evolu@onmailto:evolu@onmailto:evolu@onmailto:evolu@onmailto:evolu@onmailto:en@tymailto:presenta@onsmailto:evolu@onmailto:evolu@on
  • 8/11/2019 Dengue Hemorragic Fever

    34/93

  • 8/11/2019 Dengue Hemorragic Fever

    35/93

    3@7G*@7E 46@ D*;CU* U>E@;7;C 7C;

    ProbableDengue

    - li9e in /tra9el to dengueendemic

    area.4e9er and 2 of the followingcriteria- ;auseaF 9omi!ng

    - @ash- Eches and pains- Gourni%uet test posi!9e

    - eu"openia- En$ warning signaborator$HIconLrmed dengue :important when nosign of plasma lea"age<

    >arning ignsV

    - Ebdominal pain ortenderness- Persistent 9omi!ng

    - 3linical 8uid accumula!on- Mucosal bleed- etharg$F restlessness

    - i9er enlargment +2 cm

    - aborator$ increase in03G concurrent withrapid decrease in platelet

    count

    V:re%uiring strict obser9a!onand

    medicalinter9en!on

  • 8/11/2019 Dengue Hemorragic Fever

    36/93

    aborator$HIconLrmed

    dengue

    :important when no sign of plasma lea"age<

  • 8/11/2019 Dengue Hemorragic Fever

    37/93

    3@7G*@7E 46@ *=*@*

    D*;CU*

    e9ere

    plasmalea"ageleading

    to

    - hoc" :D06 ,''

    >06 *E@6

    2#,,

    mailto:De%EF%AC%81ni@onmailto:De%EF%AC%81ni@onmailto:De%EF%AC%81ni@onmailto:De%EF%AC%81ni@onmailto:De%EF%AC%81ni@onmailto:De%EF%AC%81ni@on
  • 8/11/2019 Dengue Hemorragic Fever

    40/93

    3linical 3ase DeLni!on

    Probable Dengue4e9er

    3onLrmed Dengue4e9er

    - 4e9er of 2 to da$sdura!onF with two ormore of the following

    - 0eadacheF retroorbitalpainF m$algiaF arthralgiaF rashFhemorrhagic

    manifesta! onsFleu"openiaF andsuppor!9e serolog$ oroccurrence at the sameloca!on and !me asother conLrmed cases

    ofdengue.

    mailto:De%EF%AC%81ni@onmailto:De%EF%AC%81ni@onmailto:De%EF%AC%81ni@onmailto:De%EF%AC%81ni@onmailto:dura@onmailto:dura@onmailto:dura@onmailto:dura@onmailto:dura@onmailto:manifesta@onsmailto:manifesta@onsmailto:manifesta@onsmailto:manifesta@onsmailto:suppor@vemailto:suppor@vemailto:suppor@vemailto:suppor@vemailto:suppor@vemailto:loca@onmailto:loca@onmailto:loca@onmailto:loca@onmailto:loca@onmailto:De%EF%AC%81ni@onmailto:dura@onmailto:dura@onmailto:manifesta@onsmailto:manifesta@onsmailto:suppor@vemailto:suppor@vemailto:loca@onmailto:loca@on
  • 8/11/2019 Dengue Hemorragic Fever

    41/93

  • 8/11/2019 Dengue Hemorragic Fever

    42/93

  • 8/11/2019 Dengue Hemorragic Fever

    43/93

    -Probable case and at least one of thefollowing

    - 7sola!on of dengue 9irus from serumF34 orautops$ samples.

    - 4ourfold or greater increase inserum 7gC :b$ 07 test

  • 8/11/2019 Dengue Hemorragic Fever

    44/93

    3linical 3ase DeLni!on

    mailto:De%EF%AC%81ni@onmailto:De%EF%AC%81ni@onmailto:De%EF%AC%81ni@onmailto:De%EF%AC%81ni@onmailto:De%EF%AC%81ni@on
  • 8/11/2019 Dengue Hemorragic Fever

    45/93

    >06 Crading of D04

  • 8/11/2019 Dengue Hemorragic Fever

    46/93

  • 8/11/2019 Dengue Hemorragic Fever

    47/93

    3linical Management ofD04

  • 8/11/2019 Dengue Hemorragic Fever

    48/93

    Principle of D04

    Management Primar$ abnormali!es

    in

    D04

    =asculopath$

    Ghromboc$topeniaGhrombopath$

    3oagulopath$ e9ere D73

    mailto:abnormali@esmailto:abnormali@esmailto:abnormali@esmailto:abnormali@esmailto:abnormali@es
  • 8/11/2019 Dengue Hemorragic Fever

    49/93

    trateg$ of D04

    Management uppor!9e therap$

    Drug as

    indicated

    Plasma lea"age olume replacement 0ow to choose 8uid solu!on

    25( need colloid

    3linical course of D04 unpredictable monitoring

    *arl$ detec!on and prompt treatment of

    circulator$ disturbance clinicall$ Z P3=

    bleeding manifesta! on clinicall$ and lab

    mailto:Suppor@vemailto:Suppor@vemailto:Suppor@vemailto:solu@onmailto:solu@onmailto:solu@onmailto:solu@onmailto:detec@onmailto:detec@onmailto:detec@onmailto:detec@onmailto:manifesta@onmailto:manifesta@onmailto:manifesta@onmailto:manifesta@onmailto:Suppor@vemailto:solu@onmailto:detec@onmailto:manifesta@on
  • 8/11/2019 Dengue Hemorragic Fever

    50/93

  • 8/11/2019 Dengue Hemorragic Fever

    51/93

    6utpa!ent management ofpa!ents

    withdengue

    -arly

    dengue Q#( of pa!ents ma"e the Lrst 9isit to amedical

    doctor within the Lrst 2 da$s of fe9er

    followHIup card diagnosis of

    suspected

    dengueF

    serial

    fullHIbloodHIcount results :to includeF at leastFhaematocrit

    [er$throc$te

    9olume

    frac!on\